Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRIAN MICHAEL LINGERFELT

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1942418744
CMS profile
269340
Location
CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,491.00

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,491.00 115

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRIAN MICHAEL LINGERFELT

NPI 1942418744 · CMS profile ID 269340

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1942418744?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1942418744?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1942418744?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
BRIAN MICHAEL LINGERFELT, NPI 1942418744, CMS profile ID 269340, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1942418744?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $2,491.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Pharmacyclics LLC, An AbbVie Company $14.1307/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998289751 CMS
G1 Therapeutics, Inc. $15.9907/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059917185 CMS
E.R. Squibb & Sons, L.L.C. $17.9007/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410533 CMS
Astellas Pharma US Inc $17.4707/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034258695 CMS
Genentech USA, Inc. $21.6907/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040317301 CMS
Genmab U.S., Inc. $20.1507/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051343043 CMS
Regeneron Healthcare Solutions, Inc. $28.2606/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999276079 CMS
GlaxoSmithKline, LLC. $14.0406/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002677189 CMS
Lilly USA, LLC $22.1606/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031299521 CMS
Daiichi Sankyo Inc. $26.9406/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006446815 CMS
Incyte Corporation $22.5606/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044496757 CMS
E.R. Squibb & Sons, L.L.C. $0.4706/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410507 CMS
E.R. Squibb & Sons, L.L.C. $1.2706/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410509 CMS
E.R. Squibb & Sons, L.L.C. $13.2506/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410513 CMS
MENARINI SILICON BIOSYSTEMS, INC. $21.5206/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060586475 CMS
PFIZER INC. $21.1906/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050468519 CMS
Novartis Pharmaceuticals Corporation $38.2506/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992295041 CMS
Novartis Pharmaceuticals Corporation $19.8306/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992295037 CMS
AstraZeneca Pharmaceuticals LP $14.4906/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015204427 CMS
GlaxoSmithKline, LLC. $19.3305/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002681341 CMS
Regeneron Healthcare Solutions, Inc. $28.5905/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999276075 CMS
Daiichi Sankyo Inc. $29.2705/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006434337 CMS
Eisai Inc. $24.0205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023304311 CMS
Janssen Biotech, Inc. $25.6805/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988510337 CMS
Merck Sharp & Dohme LLC $18.9405/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048647019 CMS
Regeneron Healthcare Solutions, Inc. $19.4805/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999276071 CMS
Seagen Inc. $19.6005/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995717299 CMS
BeiGene USA, Inc. $20.6305/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051178279 CMS
Gilead Sciences, Inc. $28.0805/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025580539 CMS
Novartis Pharmaceuticals Corporation $18.1404/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992295021 CMS
Regeneron Healthcare Solutions, Inc. $2.3704/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999276067 CMS
Eisai Inc. $24.5704/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023304313 CMS
PFIZER INC. $16.1004/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050562467 CMS
Merck Sharp & Dohme LLC $19.6504/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048647057 CMS
Daiichi Sankyo Inc. $29.9604/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006347207 CMS
Eisai Inc. $23.5503/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023304309 CMS
AstraZeneca Pharmaceuticals LP $20.6203/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011248759 CMS
E.R. Squibb & Sons, L.L.C. $16.4703/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410475 CMS
Janssen Biotech, Inc. $23.8403/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988510345 CMS
Rigel Pharmaceuticals, Inc. $16.2703/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033381445 CMS
ARRAY BIOPHARMA INC $15.5303/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049537991 CMS
Celgene Corporation $17.3603/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410479 CMS
Gilead Sciences, Inc. $16.5903/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025943505 CMS
Novartis Pharmaceuticals Corporation $20.3002/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992295033 CMS
Janssen Biotech, Inc. $19.5902/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988510329 CMS
PFIZER INC. $18.8702/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049200193 CMS
Genentech USA, Inc. $22.3702/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040317313 CMS
E.R. Squibb & Sons, L.L.C. $12.5302/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016410445 CMS
PFIZER INC. $17.6702/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050396031 CMS
Seagen Inc. $17.3502/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995717151 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,175.57 116
PY2020 $1,732.91 89
PY2021 $2,113.60 106
PY2022 $2,554.88 126
PY2023 $2,491.00 115
PY2024 $2,009.19 95
PY2025 $2,214.78 89

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,828.50 7
PY2024 Principal investigator $11,255.88 6
PY2023 Principal investigator $22,465.15 8
PY2022 Principal investigator $57,202.74 18
PY2021 Recipient $2,576.00 1
PY2021 Principal investigator $188,562.75 29
PY2020 Principal investigator $426,518.06 44
PY2019 Recipient $10,385.00 3
PY2019 Principal investigator $337,286.94 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $411.00 09/04/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738153
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,500.00 09/04/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738155
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $68.00 05/28/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738149
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $56.00 05/28/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738151
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $278.00 05/02/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738147
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $223.00 02/20/2025 Non-covered Recipient Entity
CLINICAL BIOTECHNOLOGY RESEARCH INSTITUTE AT RSFH
EMERGE 402: Phase IV Observational Study to Collect Safety and Outcome Data in Real-World Setting in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Zepzelca No dispute reported 06/30/2026 1233738145
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $10,292.50 02/06/2025 Non-covered Recipient Entity
Rsfpp Orthopedic Charleston Hand Group
Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies No dispute reported 06/30/2026 1235994135